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ABSTRACT
Introduction Cerebral visual impairment (CVI) refers 
to a spectrum of brain- related vision problems. CVI is 
associated with poor educational and mental health 
outcomes. An intervention has been developed to 
help children with CVI, involving input from clinicians, 
teachers and parents. The effectiveness of this 
intervention needs to be evaluated. This study aims 
to guide any refinements to the intervention or the 
design of a future cluster- randomised trial that may be 
needed.
Methods and analysis This study will include all 
methods anticipated for a future cluster- randomised 
controlled trial. Eight primary schools will be recruited 
and randomised to receive the intervention or carry 
on with usual practice. The intervention will comprise 
an information pack for schools and access to a local 
paediatric ophthalmology clinic (who are prepared 
to assess them for CVI), for up to 5% of participating 
children. Outcome assessments will be carried out at 
baseline (before randomisation) and after 4–5 months 
of intervention period. Assessments will include 
children’s self- reported quality of life, their learning 
ability and behaviour as reported by teachers, and family 
functioning reported by parents. Cost data will include 
service use, family expenditure on additional support 
(eg, private appointments and administration) and 
school spending and resource used in helping children 
with special educational needs or disability. A process 
evaluation (PE) will collect additional data relating to 
the implementation of the intervention and the trial 
processes, in the school and clinic settings. The protocol 
for the PE will be reported separately.
Ethics and dissemination Ethical permission was 
obtained from the University of Bristol Faculty of Health 
Sciences Ethical Committee. The results will inform the 
design of a future trial to assess the effectiveness and 
cost- effectiveness of the intervention and will be shared 
with participants, CVI- support groups and peer- viewed 
journals.
Trial registration number ISRCTN13762177; Pre-results.
INTRODUCTION
Damage or poor function in the brain areas 
related to vision leads to brain- related visual 
impairment, also known as cerebral visual 
impairment or impairments (CVI).1 There 
is not yet consensus on the specific type or 
severity of vision problems that should warrant 
a diagnosis of CVI, but there is general accep-
tance that brain- related vision disorders are 
important and a major cause of registrable 
blindness in the UK and other developed 
countries.2 A recent review suggested CVI was 
a verifiable visual impairment not attributable 
to ocular or optic nerve problems.3 Children 
with CVI may not be identified if they have 
good visual acuity;4 hence are not detected in 
visual screening programmes recommended 
for reception year (age 4–5 years) children.5 
They are therefore at risk of poor outcomes 
because of lack of support.
Strengths and limitations of this study
 ► All elements/methods proposed for the future 
cluster- randomised controlled trial will be included, 
which will allow refinements to be made if needed.
 ► A detailed, mixed methods process evaluation is 
embedded.
 ► Children with cerebral visual impairment are not in-
dividually identified and the primary analysis will be 
instead a group presumed to be enriched with af-
fected children, which will limit the statistical power.
 ► The duration of the study is limited to two terms so 
we cannot estimate long- term changes in imple-
mentation or effect.
 ► There is no provision to interview general practi-
tioners to understand their views on the suggested 
referral pathway.
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Simple strategies can be helpful for children with CVI, 
including decluttering presentations, using a window to 
isolate part of the page, or using plain backgrounds.6 
Decluttering can also increase engagement with lessons 
for children without known problems.7 However, there 
are no recommendations for teachers regarding CVI or 
vision problems in general and if these have been diag-
nosed, the child is usually referred to a specialist teacher 
(a qualified teacher for the visually impaired (QTVI)).
In a recent study by our group, at least 3.4% of all the 
children in primary schools we surveyed had CVI- related 
vision problems.8 We found that none of the potential 
indicators of higher risk for CVI- related vision problems 
(red flags) we examined were very accurate: having extra 
educational help was 79% sensitive but only 49% specific, 
while by contrast a vision- specific questionnaire was 91% 
specific but had only 13% sensitivity.
Development of the complex intervention
We have developed a multilevel intervention that aims 
to improve outcomes for children with CVI. The inter-
vention involves sharing information about the condition 
with the teachers, empowering them to try relevant strat-
egies for children who are struggling and improving links 
between schools and the paediatric ophthalmology clinic.
Our previous study8 has suggested that on average 
at least one child per class has CVI- related vision prob-
lems and that the questionnaires we used do not accu-
rately identify affected children in a community setting. 
The intervention therefore emphasises to teachers that 
universal approaches (eg, decluttering classrooms) will 
be helpful, as well as additional targeted approaches for 
children who are struggling. In this way, all children are 
exposed to potentially helpful ‘vision- friendly’ surround-
ings and there is less risk of a child getting no support 
because they are not yet diagnosed. A tiered approach 
using universal as well as targeted support has been 
recommended for other conditions affecting children, 
including anxiety and mental health problems.9 10
Families have told us that referrals to the eye clinic and 
treatment there can be difficult if there is little under-
standing of CVI. Another aspect of the intervention was 
therefore to provide an enhanced interface between the 
school and the eye clinic, by ensuring that the clinic was 
equipped and willing to accept referrals of children who 
may have CVI.
The school intervention pack materials were complied 
with advice from our professional advisory group (see 
below) and our local authority QTVIs and comprise the 
following:
1. A short (30 min) presentation with audio commen-
tary by the study principal investigator (CW) giving an 
overview of CVI and how to help affected children and 
of the other materials provided, plus a transcript of the 
presentation.
2. Links to existing online resources about CVI.
3. A ‘Toolkit’—a word document detailing simple, inex-
pensive strategies (a) for universal use with whole class 
or school and (b) targeted measures to help individual 
children who are struggling with learning. These were 
reviewed and amended by our local QTVIs.
4. Some teaching resources (stories and suggested activi-
ties for children to do), matched to the curriculum, for 
teachers to use to help explain topics related to vision 
and light.
5. Guidance for teachers as to which children may have 
CVI and which may benefit from a referral to the eye 
clinic including suggested referral criteria.
6. Letters for teachers to give to parents to show their 
general practitioners (GPs), requesting referral to 
the local paediatric ophthalmology clinic because 
vision problems are suspected. At the request of the 
University Faculty Ethical Committee, the number 
of study referrals was capped at 5% of participating 
children (to avoid overburdening the GPs or the eye 
clinic) although GPs can make whatever referrals they 
want outside of the study, in the usual way.
The eye clinic intervention materials comprise the 
following:
1. A validated questionnaire to score risk for CVI in at- 
risk children.11
2. A protocol for vision tests to identify CVI- related vision 
problems, as used in our earlier study.8
3. Sample advice sheets on how to help children with 
CVI, adapted from existing websites and resources12 13 
augmented with input from our local QTVIs.
4. A link to a secure Research Electronic Data Capture 
(REDCap, v9) database to enter the results of the vi-
sion tests and print out a summary report to give the 
families, schools and for the clinic notes.
As part of the process described by the Medical Research 
Council for the development of complex interventions,14 
we need to evaluate this intervention and see if in real 
life, the intervention might need changing or adapting.
When and if we have evidence that the intervention is 
helpful, we will make the study materials including the 
advice sheets, available on request on our website ( www. 
thecviproject. co. uk).
How the intervention might work?
There are several pathways by which the intervention 
might potentially improve outcomes for children with 
CVI, for example, teachers adapting their teaching 
methods, or accurately identifying and referring affected 
children to the eye clinic. We have conceptualised these 
in a logic model and designed a process evaluation (PE) 
to collect data on what changes in school processes or 
attitudes if any, actually occur. We report the protocol for 
this separately (in press BMJ Open).
Aim and objectives of this feasibility cluster-randomised 
controlled trial (cRCT)
The aim of this study is to assess the feasibility and accept-
ability of the new intervention and of the proposed trial 
methods, to inform the development of a future fully 
powered cluster- randomised controlled trial.
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Our specific objectives are to collect data on the 
following:
Intervention- related outcomes as follows:
1. How the intervention is implemented in practice?—a 
detailed PE has been designed to do this as reported in 
a separate protocol paper (ref).
2. Any changes in the outcome data (see table 1) that 
may indicate an effect of the intervention, to help us 
calculate the sample size needed for the future trial.
3. Attitudes of teachers and parents to the intervention 
and whether it is beneficial.
Study design- related outcomes as follows:
We will document the following:
1. The response rate and yield from recruitment flyers, 
letters and emails sent, any reasons given for non- 
participation and retention of schools once recruit-
ed (once they have signed the study paperwork—see 
below).
2. The proportion and demographic predictors of paren-
tal non- agreement to data sharing in schools that have 
been recruited.
3. The completeness of data from (a) child- report, (b) 
teacher- report and (c) parent questionnaires.
4. The number of children suggested by the schools for 
a referral to the eye clinic, the proportion that attend 
the eye clinic and of those, the proportions who do 
and do not have any CVI- related vision problems.
METHODS AND ANALYSIS
Design
The design of this feasibility cRCT is shown in the flow-
chart in figure 1. The processes for children referred to 
the eye clinic as part of the intervention are shown in 
figure 2.
Setting
The study will involve primary schools in three areas of 
England, UK: Gloucestershire, Somerset and South-
ampton. These areas were chosen because the local 
paediatric ophthalmologists have agreed to participate 
in the study. The study will be led by the study team in 
Bristol, UK.
Inclusion criteria
All mainstream state- funded primary schools including 
academies, local authority- maintained schools and free 
schools, within 1 hour of travel time to the local ophthal-
mology unit, in the three study areas will be eligible for 
inclusion.
Exclusion criteria
Schools who share a special educational needs and 
disability coordinator (SENCo or SENDCo), where 
contamination between intervention to control schools 
might occur, unless they are part of a linked group of 
schools who all participate in the trial (and will be in the 
same arm).
Enrolment of schools
All schools in the study areas that meet the inclusion 
criteria will be sent an invitation letter and copies of the 
school and parent/carer information sheets. Invitation 
letters and information sheets will be sent out by post 
and email to heads, SENCos and heads of governors. The 
letters and information sheets will explain the study and 
that schools will be reimbursed for the teachers’ time 
completing outcome assessments.
Legal basis for conducting the study
The legal basis for the study will be the University of 
Bristol undertaking a public task, as described in articles 
Table 1 Assessment tools to be used
Respondent Concept being investigated Tool Format
Child Quality of life PedsQL Generic Core Scales:
Child report: 8–12 years or child 
report: 5–7 years (supported by adult 
report)
Paper, in the classroom and supported 
by school staff
Which form the child completes is at 
discretion of their teacher
Teacher Child learning ability PedsQL cognitive scales Online REDCap form— one per child
  Child behaviour at school SDQ with impact supplement Online REDCap form—one per child
  Child behaviour that may 
indicate CVIs
5- item CVI questionnaire Online REDCap form—one per child
  Teacher perception of their 
own teaching
Self- efficacy Online REDCap form—one per teacher
Parents Parental quality of life related 
to family
PedsQL family impact module Paper
Parents fill in one per child in the study
  Generic and child- related 
costs and resource input
Family expenses questionnaire 
(designed for the study)
Paper
Parents fill in one per child in the study
  Child behaviour that may 
indicate CVIs
5- item CVI questionnaire Paper
Parents fill in one per child in the study
CVI, cerebral visual impairment; PedsQL, Pediatric Quality of Life Inventory TM; REDCap, Research Electronic Data Capture; SDQ, Strengths 
and Difficulties Questionnaire.
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6.1e and 9.2j of the European Union General Data Protec-
tion Regulation (EU-GDPR). It will not be on the basis of 
parental consent.
The head teacher will agree to participate on behalf 
of the children and staff in their school and will sign a 
Memorandum of Understanding to this effect with clear 
descriptions of the expectations and obligations of the 
study team and the participating school. This will be non- 
binding and is written to foster mutual understanding of 
what is involved—there will be no steps taken if schools 
are unwilling or unable to carry out all their activities. A 
link to the full privacy notice online will be provided to 
all parents and school staff and a summary of the privacy 
notice is included in the parent/carer information sheet 
(PIS) and the school information sheet.
Any parent in a participating school will be able to 
withdraw their child’s data from the study. This can be 
achieved by contacting the study team using details 
Figure 1 The CVI project feasibility trial flowchart. CVI, cerebral visual impairment; GP, general practitioner; REDCap, Research 
Electronic Data Capture; SDQ,Strengths and Difficulties Questionnaire; SENCO, special educational needs and disability 
coordinator.
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included in the PIS, or by completing a non- agreement 
to data use form that will all be sent with a PIS, plus a 
freepost envelope. They will be able to do this at any time 
up to the end of the study. In addition, if a child does not 
assent to filling in the child- report questionnaires, they 
do not have to. They will still be included in the study 
unless their parent has withdrawn them.
Study set-up and baseline assessments
An excel sheet will be completed by the school with 
name, gender, date of birth, school pupil number, status 
regarding free school meals, siblings at the school and the 
level of and reason for extra educational help, for all chil-
dren in Y3–Y5. Unique study identification (ID) numbers 
for each child will be generated. The study team will then 
provide a PIS and a questionnaire for each family, plus 
self- completion forms for the children, all with individual 
study ID numbers.
Outcome assessments were selected from the litera-
ture suggesting that unsupported CVI can impair chil-
dren’s learning15 16 and from a core outcome set study 
identifying outcomes relating to CVI in children that 
were rated as important by families and professionals 
(paper in preparation). The assessment tools to be used 
are summarised in table 1. The children will be asked to 
complete the child- report Pediatric Quality of Life Inven-
tory TM(PedsQL) quality of life (QoL) scales.17 The 
teachers will be asked to complete the PedsQL cognitive 
scales which estimate the children’s ability to learn18 and 
Goodman’s Strengths and Difficulties questionnaire.19 
The parents will be asked to complete the PedsQL Family 
Impact Module20 and a resource use questionnaire devel-
oped for the study (see below and a copy is given as online 
supplemental material). Both teachers and parents will 
also be asked to complete a short vision- specific question-
naire which elicits behaviours suggestive of CVI.21 Finally, 
the teachers will be asked to complete a questionnaire 
about their perception of their own teaching skills and 
abilities.
The study team will send or deliver to schools all the 
materials they need (school information sheet and PIS, 
child questionnaires and parent questionnaires). The 
parent and child questionnaires will all have a front sheet 
giving the child’s name, class and study ID number, while 
the actual questionnaires will have only the study ID. On 
completion, the front sheets will be removed and the data 
returned to the study team with study ID only, by freepost 
envelope for the parent questionnaires and child- report 
forms will be collected from the school by a member of 
the study team.
Teachers will get a link to an online questionnaire 
generated by a REDCap database and will complete one 
for each child in their class, plus answer the self- efficacy 
questionnaire relating to their own teaching practices. A 
schedule showing when the assessments will be carried 
out is shown in online supplemental material.
Randomisation
After baseline data are collected, a statistician outside the 
study will randomise the participating schools, with two 
stratification variables (a) ≤15% children having SEND 
versus >15% children having SEND and (b) three or 
more classes per year versus two or fewer classes per year.
The schools will be informed of their allocation by 
email and telephone call, all on the same day.
Postrandomisation
Study schools
Schools allocated to the intervention group will be sent 
the CVI intervention pack (by post and by email) and 
the referral letters to use if they want to suggest a child 
is seen in the eye clinic. They will be asked to study these 
as early as possible; however, the actual timing and use of 
the packs will be examined in detail in the PE.
Control schools
Schools allocated to the control group will be asked to 
carry on as normal.
Duration of study period
For pragmatic reasons (limited availability of time and 
funds), the intervention period (the length of time 
between giving the schools the intervention pack and 
Figure 2 The process of referral to the eye clinic for 
intervention schools. CVI, cerebral visual impairment; GP, 
general practitioner, ID, identification.
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collecting the outcome data) will be of two terms; whereas, 
in the full trial it is expected that the intervention period 
would be a full year.
Health economic evaluation
It is anticipated that the future trial will involve a cost- 
utility analysis, from a public sector perspective that 
includes family, education and health service costs. We will 
collect data from parents on their children’s use of NHS 
primary and secondary care resource use and any addi-
tional costs incurred to support their child’s health and 
educational needs. This will include time spent pursuing 
specialist appointments and other administrative tasks as 
well as costs related to their child’s vision. A copy of this 
questionnaire is included as a online supplemental file.
We will collect data from schools about the resource 
they allocate to supporting children with SEND, in terms 
of numbers and hours of learning support assistants, 
costs of any special equipment and requests for external 
specialists for example, speech and language therapists. 
We will collect data from the eye clinics about numbers of 
study children who attend after referral by the teachers, 
the staff involved, the average time for appointments and 
the cost of equipment needed. The costs of delivering the 
intervention by schools will be explored in the process 
evaluation.
Blinding and contamination
It will not be possible to blind school staff as to which arm 
of the study they are in, or the fieldwork staff, however 
analysis of the quantitative data will be carried out by a 
separate statistician who is blind to group allocation. The 
primary outcome for the definitive trial is planned to be 
the child’s self- reported QoL which should be subject to 
less allocation bias than the teacher- report would be. The 
feasibility of collecting the child- report data is therefore 
an important outcome from this study. The intervention 
group schools will be asked not to share the intervention 
materials; however, it is recognised that contamination 
between arms may occur and the PE will investigate this. 
If there is sharing of information by schools or by parents, 
we will note this and decide what changes should be made 
to the parent information leaflets provided in the future 
trial.
Sample size
As this is a feasibility cRCT, formal power calculations 
are not appropriate. Based on our previous study,8 we 
aim to recruit adequate primary schools so that 1300 
children are involved. Assuming data returns of 95% 
and a prevalence of 3.5% of CVI- related vision prob-
lems, this would give approximately 22 children with 
CVI- related vision problems each arm, most of whom 
are expected to be in the group of children having 
extra educational help. Depending on class sizes and 
structure, we estimate eight schools will be recruited 
and randomised.
Analysis
Analyses will be mainly descriptive and will include 
95% CIs wherever appropriate. For between arm compar-
isons, an intention- to- treat approach will be used.
Recruitment
We will report the numbers of flyers and invitation letters 
sent by post and email, and the yield from these to see 
which produces the highest number of schools agreeing 
to take part. We will report the numbers and proportions 
of children whose parents elect not to share their data. We 
will compare these results with those published by other 
trials involving primary schools and consider whether any 
changes in approach would be needed for a full trial.
Outcome assessment data
We will report the numbers and proportions of partici-
pating children for whom we receive child- report, teacher- 
report and parent- report outcome data at baseline and at 
follow- up. We will report the proportion of missing data 
within returned questionnaires.
We will examine and describe all the questionnaire data 
from children, teachers and parents. Although this is a 
feasibility study rather than the definitive trial, it will be 
useful to see the direction and magnitude of any change 
in the QoL or learning ability scores during the study. 
We do this for all children and for the subgroup having 
extra educational help, who we expect will have a higher 
prevalence of CVI- related vision problems based on our 
prevalence study in which 42% of children having extra 
help had one or more CVI- related vision problems.8 
Therefore, we expect this group to be on average more 
sensitive to the effects of any vision- enhancing interven-
tions they receive. As we cannot be sure who has CVI or 
CVI- related vision problems without examining all the 
participants, which would be unfeasible in real life, we 
will consider the group having extra educational help as 
a sample that is enriched with children who have CVI. 
We will also look specifically at the outcome data for any 
intervention group children referred to the eye clinic 
and diagnosed with CVI. We will estimate the number of 
children referred who do not have any CVI- related vision 
problems, as an indicator of how accurate the teacher 
referrals are.
We will use these data to guide the plans for the design 
and analysis of the future trial and estimate the numbers 
that will be needed for the trial to have appropriate statis-
tical power.
Health economic evaluation
The health economic analysis will also be predominantly 
descriptive. Item- level missing data and the return of 
adult and child questionnaires will be explored. As the 
intervention is predominantly delivered outside of the 
NHS, data on individual level resource use in this study is 
mostly reliant on parent report. The data quality will be 
explored to inform the refinement of questionnaires and 
utility of pursuing linked data collection in a future trial. 
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Completion and return of school and NHS eye clinic data 
will also be examined.
There is extensive literature22 mapping the PedsQL to 
the CHU9D, so we will estimate quality- adjusted life years 
associated with any change in QoL. The possibility of 
alternative frameworks including broader outcomes, such 
as cost- consequence analyses, will also be explored.
Governance
The study will be managed day- to- day by the study team. 
Expert advice will be available from the study advisory 
groups. A Trial Steering Committee (TSC), chaired by an 
independent expert academic, will oversee the conduct 
of the study. The TSC will discuss the study results and 
findings with the study team and will advise on the final 
decision of whether to apply for funding for a full trial, 
with modifications to the intervention or study methods 
if indicated.
Patient and public involvement
Our parents advisory group (comprising parents of chil-
dren with CVI) have advised on the design and materials 
for the study at several timepoints. At the outset they 
agreed that informing teachers about CVI and how to 
help affected children was an important intervention. 
They recommended including outcomes related to child 
learning ability as well as well- being. They recommended 
that the control group of schools be offered the interven-
tion materials at the end of the study and that the schools 
would need reimbursing for the teachers’ time spent 
filling in questionnaires.
At subsequent meetings they revised the wording of the 
PIS. They commented on the assessment tools (table 1) 
and recommended that parents might find some ques-
tions off- putting so we agreed that using just the Strengths 
and Difficulties Questionnaire (SDQ) impact module was 
best for parents. Parents also suggested the term ‘vision 
-friendly’ for measures like decluttering. They suggested 
emphasising to teachers the low cost and ease of the 
simple measures suggested and that they would be useful 
as evidence for Ofsted (the national schools’ regula-
tory body), of interventions the teachers were using to 
support learners. They chose the family impact module 
above another questionnaire as a tool for capturing the 
family perspective.
We also have a professionals advisory group (a QTVI, a 
community paediatrician, an educational psychologist, a 
head teacher, a SENCo, an orthoptist and a public health 
consultant). This group have advised regularly on the 
study materials and design, specifically on the approach 
to schools, the scheduling of recruitment, the wording of 
the intervention pack materials and the referral process 
for children to get to the eye clinic.
ETHICS AND DISSEMINATION
Ethical approval for the protocol of this study was 
obtained from the University of Bristol Faculty of Health 
Sciences Ethics Committee (FREC ref: 89144) in August 
2019. The committee requested changes to the protocol 
when first submitted: giving parents more detail about 
CVI in the PIS and capping the number of referrals to the 
eye clinic to prevent the GPs or eye clinic being overbur-
dened. Once we had made these changes, a favourable 
opinion to the study was granted.
The study is registered on the International Standard 
Randomised Controlled Trial Number registry. Approval 
from the Health Research Authority (HRA- Ref 19/
HRA/6124) has been obtained.
Results from this study will be submitted to peer- 
reviewed journals and presented at scientific conferences. 
Summaries will be made available to participating schools, 
our advisory groups and family support group websites 
and social media platforms. A meeting for all participants 
and collaborators will be held to present the findings. If 
indicated, the results will be used in a funding application 
for a future trial.
TRIAL STATUS
Recruitment for this trial began in August 2019 and 
closed in December 2019. Baseline data were collected 
in December 2019 and January 2020, then the schools 
were randomised and informed of their group allocation. 
Intervention packs were delivered to schools in March 
2020. The study was paused in March 2020 because of 
the COVID-19 pandemic. At the time of submission (14 
September 2020), we have obtained FREC and HRA 
permission to restart the study, with minor amendments 
to the protocol in line with COVID-19 precautions. 
Follow- up data will be collected in January 2021. The 
COVID-19 amendments will be reported with the results.
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